Rita Lin

2.8k total citations · 1 hit paper
22 papers, 2.2k citations indexed

About

Rita Lin is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, Rita Lin has authored 22 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 16 papers in Hepatology and 4 papers in Rheumatology. Recurrent topics in Rita Lin's work include Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (6 papers). Rita Lin is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (6 papers). Rita Lin collaborates with scholars based in Australia, Indonesia and Brazil. Rita Lin's co-authors include Dev Samarasinghe, Geoffrey C. Farrell, Christopher Liddle, Shivakumar Chitturi, Jacob George, Martin Weltman, Jason M. Hui, Shehan Abeygunasekera, Rooshdiya Z. Karim and Caroline Fung and has published in prestigious journals such as Hepatology, Gut and The Journal of Infectious Diseases.

In The Last Decade

Rita Lin

22 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

2002 936 citations Shivakumar Chitturi, Shehan Abeygunasekera et al. Hepatology profile →

Peers

Countries citing papers authored by Rita Lin

Since Specialization

Citations

This map shows the geographic impact of Rita Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Lin more than expected).

Fields of papers citing papers by Rita Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Lin. The network helps show where Rita Lin may publish in the future.

Co-authorship network of co-authors of Rita Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Lin. A scholar is included among the top collaborators of Rita Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Lin. Rita Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Associations between Various Sleep-Wake-Related Indicators and Nutritional Status in Community-Dwelling Older Adults: The Yilan Study, Taiwan 2023 ·The journal of nutrition health & aging ·Rita Lin, Po–Jung Pan, Nai‐Wei Hsu, Hsi‐Chung Chen	1
2	HBV vaccination and HBV infection induces HBV-specific natural killer cell memory 2020 ·Gut ·Ratna Sari Wijaya, Scott Read, Naomi R. Truong, Shuanglin Han, (unknown), (unknown), Nicole Fewings, Stephen D. Schibeci, Mahmoud Karimi Azardaryany, Grant P. Parnell, David R. Booth, David van der Poorten, Rita Lin, Jacob George, Mark W. Douglas, Golo Ahlenstiel	40
3	KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B 2019 ·Journal of Hepatology ·Ratna Sari Wijaya, Scott Read, Stephen D. Schibeci, Mohammed Eslam, Mahmoud Karimi Azardaryany, (unknown), David van der Poorten, Rita Lin, Lawrence Yuen, Vincent Lam, Jacob George, Mark W. Douglas, Golo Ahlenstiel	45
4	Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index 2004 ·Hepatology ·Archana Sud, Jason M. Hui, Geoffrey C. Farrell, Priyanka Bandara, James G. Kench, (unknown), Rita Lin, Dev Samarasinghe, Christopher Liddle, Geoffrey W. McCaughan, Jacob George	139
5	Effects of Interferon Treatment Response on Liver Complications of Chronic Hepatitis C: 9-year Follow-Up Study 2004 ·The American Journal of Gastroenterology ·(unknown), (unknown), Karen Byth, Rita Lin, Martin Weltman, Jacob George, Dev Samarasinghe, Christopher Liddle, James G. Kench, Evelyn Crewe, Geoffrey C. Farrell	46
6	Changes in Antipyrine Clearance and Platelet Count, But Not Conventional Liver Tests, Correlate With Fibrotic Change in Chronic Hepatitis C: Value for Predicting Fibrotic Progression 2003 ·The American Journal of Gastroenterology ·(unknown), Dev Samarasinghe, Rita Lin, James G. Kench, Karen Byth, (unknown), Evelyn Crewe, Christopher Liddle, Jacob George, Geoffrey C. Farrell	23
7	Effectiveness of interferon alfa‐2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting 2003 ·The Medical Journal of Australia ·Dinesh Kumar, Craig T. Wallington‐Beddoe, Jacob George, Rita Lin, Dev Samarasinghe, Chris Liddle, Geoffrey C. Farrell	18
8	Transjugular liver biopsy effecting changes in clinical management 2003 ·Australasian Radiology ·David D. Lee, Shivakumar Chitturi, James G. Kench, Jacob George, Steven A. Fuller, Ken Bradstock, Rita Lin, (unknown), Noel Young	8
9	Genotype‐specific mechanisms for hepatic steatosis in chronic hepatitis C infection 2002 ·Journal of Gastroenterology and Hepatology ·Jason M. Hui, James G. Kench, Geoffrey C. Farrell, Rita Lin, Dev Samarasinghe, Christopher Liddle, Karen Byth, Jacob George	140
10	NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome breakdown → 2002 ·Hepatology ·Shivakumar Chitturi, Shehan Abeygunasekera, Geoffrey C. Farrell, JANE HOLMES-WALKER, Jason M. Hui, Caroline Fung, Rooshdiya Z. Karim, Rita Lin, Dev Samarasinghe, Christopher Liddle, Martin Weltman, Jacob George	936
11	HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity 2002 ·Hepatology ·Shivakumar Chitturi, Martin Weltman, Geoffrey C. Farrell, David McDonald, Christopher Liddle, Dev Samarasinghe, Rita Lin, Shehan Abeygunasekera, Jacob George	184
12	Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? 2002 ·Hepatology ·Shivakumar Chitturi, Geoffrey C. Farrell, Linda Frost, Adamandia D. Kriketos, Rita Lin, Christopher Liddle, Dev Samarasinghe, (unknown)	293
13	Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistance 2002 ·The American Journal of Gastroenterology ·Jason M. Hui, Jacob George, Christopher Liddle, Rita Lin, Dev Samarasinghe, Evelyn Crewe, Geoffrey C. Farrell	12
14	Which patients with hepatitis C develop liver complications? 2000 ·Hepatology ·(unknown), Geoffrey C. Farrell, Karen Byth, Rita Lin, Martin Weltman, (unknown), Dev Samarasinghe, James G. Kench, (unknown), Evelyn Crewe, Chris Liddle	135
15	Hepatocellular proliferation and development of hepatocellular carcinoma: A case-control study in chronic hepatitis C 1998 ·Human Pathology ·Usha Dutta, James G. Kench, Karen Byth, (unknown), Rita Lin, Christopher Liddle, Geoffrey C. Farrell	31
16	Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates 1995 ·Journal of Hepatology ·Rita Lin, (unknown), Matthew Zimmerman, Simone I. Strasser, Geoffrey C. Farrell	107
17	Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C 1995 ·Hepatology ·(unknown), Karen Byth, Jacqueline Field, Christopher Liddle, Rita Lin, Geoffrey C. Farrell	18
18	Epidemiology of hepatitis C virus infection in Australia 1993 ·Gastroenterologia Japonica ·Geoffrey C. Farrell, Martin Weltman, (unknown), Rita Lin	14
19	Alpha-interferon 2b in the treatment of chronic hepatitis C: interim report of the first multicentre Australian trial 1993 ·Gastroenterologia Japonica ·Rita Lin, Christopher Liddle, Geoffrey C. Farrell, (unknown)	4
20	Prediction of response to interferon in patients with chronic active hepatitis C, and evidence that this improves hepatic metabolic function 1991 ·Gastroenterologia Japonica ·Geoffrey C. Farrell, Rita Lin, (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact